Literature DB >> 30701421

Refractory neuropathic pain from a median nerve injury: spinal cord or peripheral nerve stimulation? A case report.

Q Dewandre1, A Dubuisson2, B Kaschten2, G Reuter2, D Martin2.   

Abstract

Spinal cord stimulation (SCS) is the most frequently used neuromodulation technique even for neurogenic pain from a peripheral nerve injury although peripheral nerve stimulation (PNS) has been designed for this purpose. PNS appears less invasive than SCS or deep brain stimulation. It provides greater and specific target coverage and it could be more cost-effective than SCS because low electrical stimulation is exclusively delivered to the precise painful territory. We report a case of excellent result following median nerve stimulation at arm level after SCS failure and a 10-year history of intense pain. PNS would certainly have been considered much earlier if it was accepted and reimbursed by the Belgium National Insurance. PNS is a safe, simple, and efficient technique available for decades but it is still considered as experimental and underemployed. Belgian National Insurance fears an explosion of indications on neuromodulation if PNS was reimbursed. We consider that PNS aside SCS and other neuromodulation techniques should be made available in Belgium in case of peripheral chronic neuropathic pain.

Entities:  

Keywords:  Neurogenic pain; Neuromodulation; Neuropathic pain; Peripheral nerve stimulation; Spinal cord stimulation

Mesh:

Year:  2019        PMID: 30701421     DOI: 10.1007/s13760-018-01065-4

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  2 in total

1.  Iatrogenic nerve injuries: a potentially serious medical and medicolegal problem. About a series of 42 patients and review of the literature.

Authors:  Annie Dubuisson; Bruno Kaschten; Maximilien Steinmetz; François Gérardy; Arnaud Lombard; Quentin Dewandre; Gilles Reuter
Journal:  Acta Neurol Belg       Date:  2020-07-11       Impact factor: 2.396

2.  Dexmedetomidine alleviated neuropathic pain in dorsal root ganglion neurons by inhibition of anaerobic glycolysis activity and enhancement of ROS tolerance.

Authors:  Peibin Liu; Tufeng Chen; Fang Tan; Jingling Tian; Lei Zheng; Yingqing Deng; Jiaxin Chen; Xinjin Chi
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.